(Q39655482)

13 September 2017

title

Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients (English)

1 reference

13 September 2017

0 references

Gbenga Ogedegbe

1 reference

13 September 2017

Carol A Mancuso

1 reference

13 September 2017

John P Allegrante

series ordinal

1 reference

13 September 2017

Mary E Charlson

series ordinal

1 reference

13 September 2017

publication date

1 June 2003

1 reference

Journal of Clinical Epidemiology

13 September 2017

published in

1 reference

13 September 2017

1 reference

13 September 2017

1 reference

13 September 2017

page(s)

520-529

1 reference

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

Hypertension awareness and control in an inner-city African-American sample

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

Human agency in social cognitive theory

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

Self-efficacy and health

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

The role of self-efficacy in achieving health behavior change

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

Development and evaluation of the Osteoporosis Self-Efficacy Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

The COPD Self-Efficacy Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

Making use of qualitative research techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

Self-efficacy in health promotion research and practice: conceptualization and measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

Clinical biostatistics. LIV. The biostatistics of concordance

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

Coefficient alpha and the internal structure of tests

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

The varimax criterion for analytic rotation in factor analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

Screening for noncompliance among patients with hypertension: is self-report the best available measure?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

Adverse events, compliance, and changes in therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

A systematic review of the associations between dose regimens and medication compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

Some economic consequences of noncompliance

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

Reciprocal Determinism at the Stages of Behavior Change: An Integration of Community, Personal and Behavioral Perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900053-2

7 January 2021

10.1016/S0895-4356(03)00053-2

Identifiers

DOI

1 reference

13 September 2017

1 reference